Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Statistics

Total Valuation

STO:ELIC has a market cap or net worth of SEK 309.66 million. The enterprise value is 284.81 million.

Market Cap	309.66M
Enterprise Value	284.81M

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:ELIC has 48.54 million shares outstanding. The number of shares has increased by 44.30% in one year.

Current Share Class	48.54M
Shares Outstanding	48.54M
Shares Change (YoY)	+44.30%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.88%
Owned by Institutions (%)	16.59%
Float	20.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	63.80
PS Ratio	28.53
PB Ratio	13.26
P/TBV Ratio	13.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.36
EV / Sales	26.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.75

Current Ratio	6.75
Quick Ratio	6.75
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,278.11

Financial Efficiency

Return on equity (ROE) is -78.88% and return on invested capital (ROIC) is -50.83%.

Return on Equity (ROE)	-78.88%
Return on Assets (ROA)	-40.79%
Return on Invested Capital (ROIC)	-50.83%
Return on Capital Employed (ROCE)	-76.81%
Weighted Average Cost of Capital (WACC)	6.32%
Revenue Per Employee	5.43M
Profits Per Employee	-8.70M
Employee Count	2
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +177.33% in the last 52 weeks. The beta is 0.38, so STO:ELIC's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+177.33%
50-Day Moving Average	5.50
200-Day Moving Average	5.85
Relative Strength Index (RSI)	61.39
Average Volume (20 Days)	212,913

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:ELIC had revenue of SEK 10.86 million and -17.41 million in losses. Loss per share was -0.38.

Revenue	10.86M
Gross Profit	10.86M
Operating Income	-17.94M
Pretax Income	-17.41M
Net Income	-17.41M
EBITDA	-17.93M
EBIT	-17.94M
Loss Per Share	-0.38

Balance Sheet

The company has 24.85 million in cash and n/a in debt, with a net cash position of 24.85 million or 0.51 per share.

Cash & Cash Equivalents	24.85M
Total Debt	n/a
Net Cash	24.85M
Net Cash Per Share	0.51
Equity (Book Value)	23.36M
Book Value Per Share	0.48
Working Capital	23.36M

Cash Flow

Operating Cash Flow	-21.55M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -165.31% and -160.35%.

Gross Margin	100.00%
Operating Margin	-165.31%
Pretax Margin	-160.35%
Profit Margin	-160.35%
EBITDA Margin	-165.20%
EBIT Margin	-165.31%
FCF Margin	n/a

Dividends & Yields

STO:ELIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.30%
Shareholder Yield	-44.30%
Earnings Yield	-5.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:ELIC has an Altman Z-Score of 28.71 and a Piotroski F-Score of 2.

Altman Z-Score	28.71
Piotroski F-Score	2